Immatics (IMTX) Non-Current Deferred Tax Liability (2022 - 2025)

Immatics recorded quarterly Non-Current Deferred Tax Liability of $4.4 million in Q4 2025, up 3.06% quarter-over-quarter from $4.3 million in Q3 2025, and down 28.55% year-over-year from $6.2 million in Q4 2024.

Immatics' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $4.4 million for Q4 2025.

  • In Q4 2025, Non-Current Deferred Tax Liability fell 28.55% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (down 28.55% YoY), while the FY2025 annual figure was $4.3 million, down 30.65% from the prior year.
  • Non-Current Deferred Tax Liability came in at $4.4 million for Q4 2025 at Immatics, up from $4.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $10.0 million in Q4 2022 to a low of $3.7 million in Q3 2024.
  • A 4-year average of $6.0 million and a median of $5.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 16.59% in 2025 and fell as far as 39.56% in 2025.
  • Immatics' Non-Current Deferred Tax Liability stood at $10.0 million in 2022, then declined by 19.75% to $8.0 million in 2023, then decreased by 22.79% to $6.2 million in 2024, then decreased by 28.55% to $4.4 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $4.4 million, $4.3 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Immatics 1.80 Bn 1.80 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 4.43 Mn
Dec 31, 2025 4.43 Mn
Sep 30, 2025 4.30 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 4.31 Mn
Jun 30, 2025 4.31 Mn
Mar 31, 2025 5.06 Mn
Mar 31, 2025 5.06 Mn
Dec 31, 2024 6.20 Mn
Dec 31, 2024 6.20 Mn
Sep 30, 2024 3.69 Mn
Sep 30, 2024 3.69 Mn
Jun 30, 2024 7.13 Mn
Jun 30, 2024 7.13 Mn
Mar 31, 2024 7.23 Mn
Mar 31, 2024 7.23 Mn
Dec 31, 2023 8.03 Mn
Dec 31, 2023 8.03 Mn
Dec 31, 2022 10.01 Mn
Dec 31, 2022 10.01 Mn